Pair of genes makes plant pest double trouble

 Coloured electron microscopy image of a gold labelled pilus (blue) protruding from a Pseudomonas syringae cell (left). Image kindly provided by Prof. John Mansfield.

Research at Imperial could help scientists control one of the world's most important crop diseases, Pseudomonas Syringae - News

Monday 7 February 2011

Adapted from a news release issued by the Biotechnology and Biological Science Research Council (BBSRC).

Researchers from Imperial College London have revealed this week how two genes in the bacteria Pseudomonas syringae work together to trigger an infection responsible for a range of deadly plant diseases.

Pseudomonas causes disease outbreaks in rice, tomatoes, corn, cucumbers and beans, as well as many wild plants, and has now infected half of all horse chestnut trees in the UK. The British Society for Plant Pathology has rated P. syringae as the most important plant pathogen worldwide.

The researchers hope that their gene discovery explaining how the bacteria attack plant cells so effectively will help them find new targets for pesticides and devise better strategies for disease management.

P. syringae have a sophisticated system for infecting plants: they possess tiny needle-like structures called pili which they use to inject a plant with a range of proteins which suppress its immune response and kill cells.

What distinguishes P. syringae from other pathogens is that it has duplicated a key gene involved in producing the pili. The Imperial researchers found this duplication in all strains of P. syringae they have investigated, suggesting that its presence is very likely to enhance the infection process.

"P. syringae are quite remarkable," said senior author on the study Dr Jörg Schumacher, from the Department of Life Sciences. " They can live on plant leaves for a long time before 'freezing' rainwater to create sharp micro-icicles. These penetrate the leaf's protective outer cells, damaging them and allowing the bacteria to enter. Once inside, they use their pili to infect more susceptible cells."

The researchers were investigating how a duplicated gene could provide P. syringae with the 'edge' in terms of evolutionary advantage. They studied related systems in other bacteria in the lab of Professor Martin Buck, also in the Department of Life Sciences, and found that the two-gene system in P. syringae is an evolutionary innovation not previously described in bacteria.

Coloured microscope image of a pilus (blue) protruding from a Pseudomonas syringae cell (left). Image provided by Prof. John Mansfield.

Their findings demonstrate how evolution that happens at the molecular level translates to phenomena observed in daily life, say the researchers.

“When we see brown leaved chestnut trees next spring, chances are that P. syringae and its duplicated gene are involved," said Dr Schumacher.

Global trade of crops and live plants has helped P. syringae to spread and find new niches. Last year a number of new epidemics were reported, including outbreaks in peas in Turkey, broccoli and cabbage in South Carolina, kiwi in Italy and a particularly aggressive epidemic in tomatoes in Portugal. The bacteria infecting the British horse chestnut are thought to have come from India.

Professor Douglas Kell, BBSRC's Chief Executive said: "With improvements in imaging and modelling we are now able to look deeper into cells at how the molecular machines that underlie all life on earth work. But this is not just knowledge for its own sake; a more detailed understanding of how crop pests interact with their hosts will be important for developing more sophisticated methods of controlling them. This is vital to global food security, ensuring that we can provide safe nutritious food to a growing world population."

The research, published in Nature Communications was funded by the Biotechnology and Biological Sciences Research Council (BBSRC) and supported the Leverhulme Trust and the Wellcome Trust.

For further information please contact:

Simon Levey
Research Media Officer
Imperial College London
email: s.levey@imperial.ac.uk
Tel: +44(0)20 7594 6702
Out of hours duty press officer: +44(0)7803 886 248

Notes to editors:

1.  Jovanovic M et al "Regulation of the co-evolved HrpR and HrpS AAA+ proteins required for Pseudomonas syringae pathogenicity" is published in February edition of Nature Communications: http://dx.doi.org/10.1038/ncomms1177

2.  About The Leverhulme Trust

The Leverhulme Trust was established in 1925 under the Will of the first Viscount Leverhulme. It is one of the largest all-subject providers of research funding in the UK, distributing funds of some £50M every year. For further information about the schemes that the Leverhulme Trust fund visit their website at www.leverhulme.ac.uk.

3.  About BBSRC

B BSRC is the UK funding agency for research in the life sciences. Sponsored by Government, BBSRC annually invests around £470M in a wide range of research that makes a s ignificant contribution to the quality of life in the UK and beyond and supports a number of important industrial stakeholders, including the agriculture, food, chemical, healthcare and pharmaceutical sectors.

BBSRC provides institute strategic research grants to the following:

  * The Babraham Institute
  * Institute for Animal Health
  * Institute for Biological, Environmental and Rural Studies (Aberystwyth University)
  * Institute of Food Research
  * John Innes Centre
  * The Genome Analysis Centre
  * The Roslin Institute (University of Edinburgh)
  * Rothamsted Research

The Institutes conduct long-term, mission-oriented research using specialist facilities. They have strong interactions with industry, Government departments and other end-users of their research.

www.bbsrc.ac.uk

4. About Imperial College London

Consistently rated amongst the world's best universities, Imperial College London is a science-based institution with a reputation for excellence in teaching and research that attracts 14,000 students and 6,000 staff of the highest international quality. Innovative research at the College explores the interface between science, medicine, engineering and business, delivering practical solutions that improve quality of life and the environment - underpinned by a dynamic enterprise culture.

Since its foundation in 1907, Imperial's contributions to society have included the discovery of penicillin, the development of holography and the foundations of fibre optics. This commitment to the application of research for the benefit of all continues today, with current focuses including interdisciplinary collaborations to improve global health, tackle climate change, develop sustainable sources of energy and address security challenges.

In 2007, Imperial College London and Imperial College Healthcare NHS Trust formed the UK's first Academic Health Science Centre. This unique partnership aims to improve the quality of life of patients and populations by taking new discoveries and translating them into new therapies as quickly as possible.

Article text (excluding photos or graphics) © Imperial College London.

Photos and graphics subject to third party copyright used with permission or © Imperial College London.

Reporter

Press Office

Communications and Public Affairs